![Feng Zhou](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 69 170 $ al 30/09/2026
Feng Zhou currently works at Guoxin Venture Capital Management (Shenzhen) Co. Ltd., as Executive Director from 2017, 3D Medicines, Inc., as Non-Executive Director from 2021, and Shandong Weigao Blood Purification Products Co., Ltd., as Independent Director from 2023.
Mr. Zhou received his graduate degree in 2005 from Fudan University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
3D MEDICINES, INC. 0,07 % | 28/07/2026 | 193.500 ( 0,07 % ) | 69 170 $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| 3D MEDICINES INC. | Director/Miembro de la Junta | 09/10/2019 |
| SHANDONG WEIGAO BLOOD PURIFICATION PRODUCTS CO., LTD. | Director/Miembro de la Junta | 11/12/2023 |
Guoxin Venture Capital Management (Shenzhen) Co. Ltd. | Director/Miembro de la Junta | 01/05/2017 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Fudan University
 Fudan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shandong Weigao Blood Purification Products Co., Ltd.
 Shandong Weigao Blood Purification Products Co., Ltd. Medical SpecialtiesHealth Technology Manufactures and distributes blood dialysis equipment | Health Technology |
Guoxin Venture Capital Management (Shenzhen) Co. Ltd. | |
3D Medicines, Inc.
 3D Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio-pharmaceutical company | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
